Carlo Federico Perno

Researcher Next ID · RN-034961

Researcher · Immunology and Microbiology

Yaoundé, Italy

Accepting doctoral researchersFunding unknown

Research interests

Immunology and Microbiology

Medicine

HIV/AIDS drug development and treatment

HIV Research and Treatment

HIV/AIDS Research and Interventions

Hepatitis C virus research

Hepatitis B Virus Studies

Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study
The Lancet Infectious Diseases · 2016 · https://doi.org/10.1016/s1473-3099(15)00536-8
1,2,3-Triazole-[2,5-Bis-O-(tert-butyldimethylsilyl)-.beta.-D-ribofuranosyl]-3'-spiro-5''-(4''-amino-1'',2''-oxathiole 2'',2''-dioxide) (TSAO) Analogs: Synthesis and Anti-HIV-1 Activity
Journal of Medicinal Chemistry · 1994 · https://doi.org/10.1021/jm00050a015
Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivative
Biochemical and Biophysical Research Communications · 1989 · https://doi.org/10.1016/0006-291x(89)92756-3
Replication of human immunodeficiency virus in monocytes. Granulocyte/macrophage colony-stimulating factor (GM-CSF) potentiates viral production yet enhances the antiviral effect mediated by 3'-azido-2'3'-dideoxythymidine (AZT) and other dideoxynucleoside congeners of thymidine.
The Journal of Experimental Medicine · 1989 · https://doi.org/10.1084/jem.169.3.933
In Vivo Activity Against HIV and Favorable Toxicity Profile of 2′,3′-Dideoxyinosine
Science · 1989 · https://doi.org/10.1126/science.2502840

No projects listed.